INmune Bio (INMB) Earnings Analysis
INmune Bio (INMB) next reports earnings on 2026-08-06, consensus EPS -0.20667 USD. Last quarter (2026-05-07) it beat with EPS -0.2 USD vs -0.245 USD est (+18.4%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -1.09.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does INMB next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.20667 USD |
| Revenue estimate | 0.00B |
INMB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.2 USD | -0.245 USD | +18.4% | Beat |
| 2026-03-30 | -0.18 USD | -0.27 USD | +33.3% | Beat |
| 2025-10-30 | -0.24 USD | -0.31 USD | +22.6% | Beat |
| 2024-10-31 | -0.6 USD | -0.49 USD | -22.4% | Miss |
| 2024-08-01 | -0.5 USD | -0.63 USD | +20.6% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
INMB valuation and analyst view
| Trailing P/E | -1.09 |
|---|---|
| Trailing EPS | -1.56481 USD |
| Price / book | 2.49 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Buy (6 buy / 2 hold / 1 sell) |
Related research pages
Frequently asked questions
When is INmune Bio (INMB)'s next earnings date?
INmune Bio is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.20667 USD and revenue estimate of 0.00B.
Did INMB beat earnings last quarter?
In its 2026-05-07 report, INMB posted EPS of -0.2 USD versus a -0.245 USD estimate — a beat of 18.4%.
What is INMB's earnings track record?
Over the last 5 reported quarters with consensus data, INMB beat estimates 4 times (80%).
What is INMB's current P/E ratio and EPS?
INMB trades at a trailing P/E of -1.09 on trailing EPS of -1.5648146051469578 USD.
What do analysts rate INMB?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 6 buy, 2 hold, 1 sell, 0 strong sell).